Skip to content

A randomized control study - an efficacy of a virtual bronchoscopy made by the workstation for diagnostic bronchoscopy for peripheral pulmonary lesions -

A randomized control study - an efficacy of a virtual bronchoscopy made by the workstation for diagnostic bronchoscopy for peripheral pulmonary lesions - - Randomized Controlled Trial using ziostation (zio-RCT)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019014
Enrollment
260
Registered
2015-09-18
Start date
2015-11-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral pulmonary lesions

Interventions

Case group: diagnostic bronchoscopy with the virtual bronchoscopy made by the workstation Control group: diagnostic bronchoscopy without the virtual bronchoscopy made by the workstation

Sponsors

National Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patient with a peripheral pulmonary lesion (PPL) that is detected by thin-section computed tomography (TSCT) and its major diameter is 30mm or less 2) primary lung cancer is suspected by TSCT 3) patient is 20 years-old or more 4) written consent has been obtained with respect to participation in this study

Exclusion criteria

Exclusion criteria: 1) benign tumor or inflammatory lesion is suspected by TSCT 2) PPL contains ground-glass opacity by TSCT 3) metastatic lung tumor is strongly suspected by medical history 4) re-biopsy is aimed 5) percutaneous oxygen saturation of patient is 90% or less in room air 6) patient has complications of poorly controled 7) patient is pregnant 8) patient inplants a pacemaker 9) patient cannot stop anticoagulant and antiplatelet drugs for 3 days or more 10) written consent has not been obtained 11) other reasons that attending physician deems patient inappropriate

Design outcomes

Primary

MeasureTime frame
endobronchial ultrasound (EBUS) detection rate

Secondary

MeasureTime frame
diagnostic accuracy examination time safety

Countries

Japan

Contacts

Public ContactYuji Matsumoto

National Cancer Center Hospital Department of Endoscopy, Respiratory Endoscopy Division

yumatsum@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026